NIGHT
Sep 30 2020
Natural History of the Progression of Choroideremia Study (NIGHT) Sponsor: NightstaRx Ltd, a Biogen Company CLINICALTRIALS.GOV
Read MoreSTAR
Sep 30 2020
A Randomized, Open Label, Outcomes-Assessor Masked, Prospective, Parallel Controlled Group, Phase 3 Clinical Trial of Retinal Gene Therapy For Choroideremia Using An Adeno-Associated Viral Vector (AAV2) Encoding Rab Escort Protein 1 (REP1) (STAR) Sponsor: NightstaRx…
Read More